Results 251 to 260 of about 24,572,041 (402)

Usefulness of interleukin-1 blockade in autoinflammatory diseases. [PDF]

Reumatologia
Gagro A.
europepmc   +1 more source

Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor [PDF]

, 1988
H. Shaw Warren, G R Riveau, F. A. de Deckker, L Chedid   +3 more
openalex   +1 more source

Sugar Functionalized Collagen Material for Local Modulation of Innate Immunity

Advanced Science, EarlyView.
Modulation of the innate immune response at the implant site can significantly influence adaptive immunity. A mannose‐functionalized collagen patch, termed the Local Immunotuning Patch (LIP), has been designed to engage mannose receptors on antigen‐presenting cells while exhibiting antibacterial properties. LIP orchestrates complex immune pathways that
Francesca Taraballi, Claudia Corbo, Julia Enterria‐Rosales, John Otto Martinez, Silvia Minardi, Laura Pandolfi, Xing Wang, Ennio Tasciotti, Kavindra V. Singh, Cesar A. Arias, Bruna Corradetti   +10 more
wiley   +1 more source

IL-1 receptor antagonist production by isolated mononuclear cells is a better indicator of bioincompatibility of hemodialysis membranes than that by stimulated whole blood [PDF]

, 2000
Eigler, A., Endres, S., Schiffl, Helmut, Toepfer, Marcel, Tuma, E.   +4 more
core   +1 more source

Characterization of the interleukin‐1‐induced tyrosine phosphorylation of a 41‐kDa plasma membrane protein of the human tumor cell line K 562 [PDF]

, 1989
Michael U. Martin, David H. Lovett, Márta Szamel, Klaus Resch   +3 more
openalex   +1 more source

Targeted Delivery of α‐ketoglutarate to Macrophages in Bone: A Novel Therapeutic Strategy for Improving Fracture Healing in Type 2 Diabetes

Advanced Science, EarlyView.
The study reveals that glutaminolysis in macrophages is inhibited under type 2 diabetes mellitus (T2DM) conditions, which impedes fracture healing by reducing bone morphogenetic protein 2 (BMP2) production through increased cytosine methylation on the promoter.
Jing Wang, Jiahao Cao, Siqi Zhang, Hongli Chen, Xuebing Yu, Xinli Wang, Tianji Wang, Wei Cao, Wengang Dong, Xinsen Lin, Jia Li, Wei Lei, Yafei Feng   +12 more
wiley   +1 more source

Zabedosertib, a novel interleukin-1 receptor-associated kinase-4 inhibitor, shows a favorable pharmacokinetic and safety profile across multiple phase 1 studies. [PDF]

Front Pharmacol
Feldmüller M, Jodl SJ, Ploeger B, Wagenfeld A, Wiesinger H, Zollmann FS, Klein S, Zhang R, Rohde B, Höchel J.   +9 more
europepmc   +1 more source

Purification and characterization of human recombinant interleukin-1 beta.

, 1987
Chester A. Meyers, Kyung Johanson, L M Miles, Patrick McDevitt, P L Simon, R L Webb, M J Chen, Beverly P. Holskin, Jay S. Lillquist, Peter R. Young   +9 more
openalex   +1 more source

Anti-interleukin-1 reactive cells in Hodgkin's disease [PDF]

, 1987
H. J. Ree, James P. Crowley, Charles A. Dinarello   +2 more
openalex   +1 more source

Apoptotic Bodies Restore NAD and Mitochondrial Homeostasis in Fibroblasts

Advanced Science, EarlyView.
Mesenchymal stem cell‐derived apoptotic bodies (MSC‐ABs) target keloid fibroblasts (KFs), restoring nicotinamide adenine dinucleotide (NAD) metabolism and mitochondrial function, suppressing collagen overproduction, and rebalancing tissue homeostasis, offering a novel therapy for keloid.
Shutong Qian, Siya Dai, Chunyi Guo, Wenjun Wang, Jiajia Pang, Yichen Shen, Mingyuan Xu, Jie Hu, Wenguo Cui, Xiaoming Sun, Jinghong Xu   +10 more
wiley   +1 more source